Although serum IDO cannot be used as an independent risk factor for the prognosis of ESCC patients, its application to Cox proportional risk model can provide certain theoretical basis, indicating that elevated serum IDO level is a risk factor for poor prognosis of ESCC patients. This evidence concerns the gene IDO1 and esophageal squamous cell carcinoma.